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Abstract: Several reports have demonstrated the anticancer activities of plumbagin, 
a   naphthoquinone derivative isolated from plants belonging to Plumbaginaceae family. However, 
to the best of our knowledge, there are no reports which describe gold nanoconjugation with 
plumbagin, even though plumbagin is considered to be a promising therapeutic agent. In this 
report, we demonstrate the fabrication and characterization of gold nanoparticles conjugated with 
plumbagin (AuPB) that can reduce the toxicity of the latter, and their capacity for cellular localiza-
tion and generation of reactive oxygen species. The anticancer activity and   ability of plumbagin 
to produce reactive oxygen species was studied and compared with that of bromoderivatives 
of 1,4 naphthoquinones such as 2-bromo-1,4-naphthoquinone (2-BNQ) and 2,3-dibromo-1, 
4-naphthoquinone (2,3-DBNQ) and their gold nanoconjugates. Plumbagin and bromoderiva-
tives of 1,4 naphthoquinones in the form of gold nanoconjugates showed reduced cytotoxicity 
and apoptosis compared with the pristine compounds, ie, plumbagin, 2-BNQ, and 2,3-DBNQ. 
Interestingly, we observed that the gold nanoparticles could quench the reactive oxygen species-
generating capacity of plumbagin, 2-BNQ, and 2,3-BNQ, which is one of the main mechanisms 
of action of the naphthoquinones. Therefore, it can be concluded that conjugation with gold 
nanoparticles can reduce the cytotoxicity of these compounds.
Keywords: plumbagin, gold nanoparticles, reactive oxygen species, naphthoquinones, breast 
cancer
Introduction
In Indian Ayurvedic medicine, plants belonging to Plumbaginaceae family, which are 
a rich source of plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), have been used 
to treat a wide variety of ailments. Research in the last two decades has suggested that 
plumbagin is associated with a range of potential therapeutic or preventive effects.1–4 
Though several   studies have reported the anticancer activity of plumbagin, it is 
relatively nontoxic to normal cells.5–9 The mechanism of action of plumbagin involves 
generation of reactive oxygen species, such as superoxide radicals (O2
-) and hydrogen 
peroxide (H2O2), in the system.10,11 Thus, plumbagin has also been widely used as a 
model for studies of oxidative damage.12 The hydroxyl group of plumbagin increases 
its electrophilic properties and makes it a more potent cytotoxic molecule via its ability 
to accept electrons, which increases its capacity to generate reactive oxygen species. 
Although plumbagin has been shown to be more toxic to cancer cells, it can also be 
toxic to normal cells at high concentrations.13 In this context,   nanotechnologies offer International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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an exciting range of new therapeutic possibilities for cancer 
treatment.
In cancer nanotechnology, inorganic nanoparticles, 
especially gold nanoparticle-mediated drug delivery, might 
significantly reduce the drug doses needed, with high 
specificity, low toxicity, and better bioavailability. Recently, 
several groups14–16 including ours, have demonstrated that 
inorganic nanoparticles, especially gold nanoparticles 
(AuNP), possess enormous potential to improve the efficacy 
of several   cancer treatments.17–19 Colloidal AuNP have been 
used widely for biomedical diagnostics, drug delivery, and 
therapeutic applications in cancer. AuNP were chosen for our 
study because they have several advantages, including ease 
of synthesis, easy characterization due to the presence of a 
surface plasmon resonance band, a very high surface area, 
stability, biocompatibility, and surface functionalization. 
Gold is chemically inert but is highly reactive and catalytic 
at the nanoscale level due to its high surface to volume ratio 
and quantum size effect. Spherical AuNP (size 5 nm) shows 
a single strong surface plasmon resonance absorption band 
in the visible region around 512 nm, which has significant 
biological importance.18–20
In the present study, we demonstrated conjugation and 
characterization of gold nanoconjugates with plumbagin 
(Au-PB) and bromoderivatives of naphthoquinone, their 
cytotoxicity, localization, and capacity to generate reactive 
oxygen species. We also showed that the pristine compounds 
could induce apoptosis more effectively than the gold 
conjugates. We also observed that plumbagin, but not gold 
nanoconjugates with plumbagin and   polyethylene glycol 
(PEG)-amine (Au-PAM-PB), could inhibit p53 protein 
expression because plumbagin specifically inhibits acetylation 
of p53, which makes it susceptible to ubiquitination. We also 
analyzed bromoderivatives of 1,4 naphthoquinones (2-bromo-
1,4-naphthoquinone [2-BNQ] and 2,3-bibromo-1,4-
naphthoquinone [2,3-DBNQ]) to see if they could have a 
better conjugation effect with AuNP or show any change 
in cytotoxicity on AuNP conjugation when compared with 
Au-PB. To the best of our knowledge, there are no reports 
that describe gold nanoconjugation with plumbagin for use 
as a therapeutic agent in cancer.
Materials and methods
Synthesis of AuNP
AuNP were synthesized by wet chemical methods using 
tetrachloroauric acid (HAuCl4, Aldrich Chemicals, St Louis, 
MO) and sodium borohydride (NaBH4, Aldrich Chemicals) 
as reducing agents, as described elsewhere.17,18 Briefly, an 
aqueous solution of HAuCl4 was mixed with an aqueous 
solution of NaBH4 and mixed under vigorous stirring for 
about 16 hours. AuNP were then characterized by several 
physicochemical techniques, including ultraviolet-visible 
spectroscopy and transmission electron microscopy.
conjugation of plumbagin, 2-BNQ,  
and 2,3-DBNQ with AuNP
Initially we tried to conjugate plumbagin, 2-BNQ, and 
2,3-DBNQ (Sigma-Aldrich, St Louis, MO) with colloidal 
AuNP directly by a single incubation step. Different con-
centrations of these compounds were added to the AuNP 
solution and stirred vigorously for one hour. The solutions 
were ultracentrifuged at 18,000 rpm for one hour at 10°C in 
an OTD80B Sorvall ultracentrifuge (Thermofisher Scientific 
Inc, Waltham, MA) using a 50 2Ti rotor. The resulting loose 
pellets were used for further characterization and finally for 
in vitro cell culture experiments.
conjugation of plumbagin  
with AuNP via Peg
Several PEG backbones of sulfhydryl and PAM   chemicals, 
like PEG disulfhydryl 2000, PEG tetrasulfhydryl 20,000, 
PEG disulfhydryl 10,000, methyl PEG sulfhydryl 2000, 
PEG-amine 10,000, and PEG-diamine 2000 (SunBio 
  Corporation, Orinda, CA) were used to make Au-PEG-PB 
nanoconjugates. In the first step, the PEG molecules were 
incubated with AuNP at room temperature for one hour 
to prepare AuNP-PEG, and subsequently incubated with 
plumbagin for another hour under similar conditions to make 
AuNP-PEG-PB in line with our previously published work.20 
Finally, the nanoconjugates were centrifuged at 18,000 rpm 
for one hour at 10°C, and the loose pellets and supernatant 
were analyzed for further characterization and in vitro cell 
culture experiments.
Ultraviolet spectroscopy
Absorption of the AuNP was measured using a Shimadzu 
spectrophotometer (Shimadzu Scientific Instruments Inc, 
Columbia, MD) to identify their ultraviolet-visible spectra 
(from 800 to 200 nm with a resolution of 1 nm).
release of plumbagin from nanoconjugates
The release study for the gold nanoconjugates was done as 
described elsewhere.20 Briefly, the original pellets of gold 
nanoconjugates (Au-PEG-PB) were divided into several 
equal fractions, diluted with equal volumes of phosphate-
buffered solution (pH 7.4), and incubated for different International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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time periods (0, 0.30, 1, 2, 4, and 6 hours) at 37°C. All the 
  fractions were centrifuged at 15,000 rpm for one hour at 4°C 
after incubation. The supernatant was collected from each 
fraction and we then measured the absorbance of plumbagin 
using ultraviolet spectroscopy.
In vitro cytotoxicity studies  
with MDA-MB-231 cells
In this study, we used MDA-MB-231 cells (American Type 
Culture Collection) as a model of breast cancer cells. Cells 
were maintained in Dulbecco’s modified Eagle’s medium 
with 10% fetal calf serum and 1% antibiotics in a humidified 
5% CO2 incubator at 37°C. In order to check the functional 
activity of plumbagin and its derivatives, the cells were 
incubated for different periods of time and with different 
concentrations of the study compounds, as appropriate for 
such experiments.
MTS and thymidine incorporation assays
An in vitro cell proliferation assay was done using a colorimetric 
3-(4-5- dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium salt (MTS) assay (Promega, 
Madison, WI). Briefly, the cells were treated with 100 nM of the 
gold nanoconjugates or the pristine compounds (plumbagin, 
2-BNQ, and 2,3-DBNQ) in a 96-well plate (10,000 cells/well) 
for 48 hours, and the experiment was performed as described 
previously.21 Thymidine incorporation was also done to mea-
sure the growth proficiency of the cells. Briefly, after 48 hours 
of treatment with the compounds, 2.4 × 105 cells in a 24-well 
plate were treated with 3H thymidine for four hours (0.5 µCi, 
in RPMI with 10% fetal bovine serum per well). After washing 
with ice-cold phosphate-buffered solution, the proteins were 
fixed by adding 1 mL of ice-cold methanol into each well and 
incubated for 15 minutes at room temperature. The cells were 
then washed with water, and 300 µL of 0.2 N NaOH was then 
added to each well and incubated for 30 minutes. Two mil-
liliters of scintillation fluid was added, and the radioactivity 
was counted using a liquid scintillation counter. The extent of 
thymidine incorporation was measured as the growth profi-
ciency of the cells.
Apoptosis by Annexin V binding assay
After treating the cells for 24 hours with 100 nM of the 
pristine compounds (plumbagin, 2-BNQ, or 2,3-DBNQ), 
Au-2-BNQ, Au-2,3-DBNQ), Au-PEG-PB, or AuNP alone 
were dispersed by trypsin-ethylenediamine tetra-acetic acid 
and washed further with 1× phosphate-buffered   solution. Early 
apoptotic events were then determined using the ApoAlert 
Annexin V kit (Clontech, Palo Alto, CA) as described by the 
manufacturer. Briefly, five million cells were resuspended in 
200 µL of 1× binding buffer containing Annexin V 0.1 µg/mL 
and propidium iodide 0.5 µg/mL. The cells were analyzed by 
flow cytometry. Flow cytometric quantification of DNA was 
performed using a FACScan (Becton Dickinson, San Jose, CA) 
and data analysis was carried out using Modfit software.
Western blot analysis
The cells were incubated with the 100 nM conjugates for 
24 hours. The whole cell lysate, including the floating cells 
(total eight million cells), was collected in RIPA buffer 
supplemented with a protease inhibitor cocktail. Protein 
10 µg was loaded for blotting. Mouse monoclonal antibodies, 
p53 (DO-1, SC-126, Santa Cruz Biotechnology, Santa Cruz, 
CA) and β-actin (Sigma) were incubated overnight at 4°C 
and used for immunodetection. After washing the membrane 
with 1× phosphate-buffered solution, the membrane was 
incubated with horseradish peroxidase-conjugated second-
ary antibody (antimouse IgG, Santa Cruz Biotechnology) for 
45 minutes. The bands were visualized as per the protocols 
given in the West Pico chemiluminescence detection kit and 
the Super Signal West Pico substrate (Pierce Biotechnology, 
Rockford, IL).
Transmission electron microscopy
About one million cells were incubated with 1 µM   Au-PAM-PB 
for 24 hours. After treatment, the cells were trypsinized and 
resuspended in Trump’s fixative containing 1% glutaralde-
hyde and 4% formaldehyde in 0.1 M phosphate buffer at pH 
7.2 and processed as already described in the literature.19,22 
Thin (90 nm) sections were cut using a Reichert Ultra cut E 
ultramicrotome, placed on 200 mesh copper grids, and stained 
with lead citrate. Micrographs were taken on a TECNAI 12 
operating at 120 kV .
Spectrofluorometric analysis  
of reactive oxygen species
The cells were seeded at a concentration of 10,000 cells per 
well in a 96-well plate. After overnight incubation, the cells 
were treated with 100 nM of different AuNP/compounds/H2O2 
10 µM in serum-free Dulbecco’s modified Eagle’s medium 
for 30 minutes. Cells were then washed and resuspended in 
phosphate-buffered solution and incubated with 5 µM 2′,7′- 
dichlorofluorescin diacetate H2 (Molecular Probes, Invitrogen, 
Carlsbad, CA) in ethanol for 30 minutes in the dark. Readings 
were taken on a Shimadzu UV PC2101 (Shimadzu Scientific 
Instruments Inc) at 495 nm excitation and 523 nm emission.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Results and discussion
Plumbagin conjugated with Peg-diamine 
2000-coated AuNP
Characterizations of AuNP formed by the NaBH4 reduction 
method were performed using ultraviolet-visible spectroscopy 
which showed a characteristic surface plasmon resonance 
band at 512 nm, suggesting the formation of spheri-
cal AuNP. Plumbagin, 2-BNQ, and 2,3-DBNQ showed 
absorbance peaks at 420, 350, and 360 nm, respectively. To 
analyze whether the plumbagin, 2-BNQ, and 2,3-DBNQ 
had conjugated with AuNP, the loose pellets collected after 
centrifugation were analyzed by ultraviolet spectroscopy. 
We found that 2-BNQ and 2,3-DBNQ conjugated directly 
with AuNP. This may have been due to the bromine side 
chain in naphthoquinone where the bromo group can make 
a slight positive charge in the benzene ring, enabling weak 
bond formation between the positively charged benzene 
ring and the slight negatively charged AuNP. Therefore, 
2-BNQ and 2,3-DBNQ can conjugate with AuNP. Another 
report suggests that this may be due to the bromine 
side chain which can bond with AuNP directly, because 
bromide ions of bromoderivatives can replace the chloride 
ions in AuCl4.23 A 2-BNQ concentration of 20 µg/mL was 
used for further studies because maximum absorbance at 
350 nm was observed at this concentration (Figure 1A). 
The same concentration was chosen for 2,3-DBNQ because 
the absorption at 520 nm was maximum at 20 µg/mL 
(Figure 1B). On the other hand, AuNP with plumbagin did 
not show any absorbance at 420 nm, indicating that direct 
conjugation of plumbagin with AuNP had not taken place. 
The maximum number of naphthoquinones was attached 
to the AuNP at 20 µg/mL, beyond which aggregation took 
place instead of binding more molecules to the AuNP. The 
decrease in absorbance indicates aggregation of AuNP in 
line with our previously published work.19,20
In this context, we tried to conjugate plumbagin with 
AuNP through various sulfhydryl and amine derivatives 
of PEG molecules, whereby PEG was used as a linker 
because plumbagin did not conjugate directly with AuNP. 
Among several PEG molecules (discussed in the Material 
and methods section), PEG-diamine 2000 was found to be 
conjugated with AuNP, so we used PAM for surface func-
tionalization of AuNP, after which plumbagin was conjugated 
with AuNP without any aggregation and showed absorbance 
at 420 nm (Figure 1C), where 15 µg/mL of PAM was used for 
conjugation with AuNP.20 The dependence on absorption of 
the conjugates at 420 nm indicated that a concentration ratio 
of 30 µg/mL (with respect to 1 mL of AuNP-PAM solution) 
of plumbagin could be used for further experiments. The 
change of absorption maxima (λmax) of AuNP upon addition 
of PEG-PB, 2-BNQ, or 2,3-DBNQ, as compared with the 
spectrum for AuNP alone (λmax = 512 nm) clearly demonstrates 
a red shift in the surface plasmon resonance band maxima in 
Au-PEG-PB (λmax = 536 nm), Au-2-BNQ (λmax = 542), and 
Au-2,3-DBNQ (λmax = 535), respectively (Figure 2A–C). 
Addition of PAM compounds to AuNP caused red shifts in 
the λmax values, suggesting interaction and binding of the 
individual components with the surface of the negatively 
charged AuNP. Therefore, further experiments were done with 
the Au-2-BNQ, Au-2,3-DBNQ, and Au-PAM-PB complexes. 
According to the published literature, we hypothesized that 
the naphthoquinone-derived AuNP conjugate concept is 
based on a combination of the favorable properties of the 
AuNP and the naphthoquinone molecules when forming a 
naphthoquinone-gold nanoparticle assembly.24–26 A predicted 
schematic diagram of the Au-PAM-PB complex is shown in 
Figure 2D. According to our earlier work, the absorption peak 
at 512 nm indicates the spherical nature of the nanoparticles. 
The high wavelength indicates an association with AuNP, 
which increases the stability of the nanoconjugate and the 
hydrodynamic radius of the particles.18 The release kinetics 
of plumbagin from the Au-PAM-PB nanoconjugates was also 
analyzed, and a constant release of plumbagin was observed 
for up to 24 hours (Figure 3).
AuNP-conjugated compounds may 
reduce cytotoxicity and apoptosis
MTS assay showed that AuNP-conjugated plumbagin, 
2-BNQ, and 2,3-DBNQ (Au-2-BNQ, Au-2,3-DBNQ, and 
Au-PAM-PB) could reduce antiproliferative effects to the 
same extent as the pristine compounds (Figure 4A and 
B). Analysis of the number of cells in the S phase using 
the thymidine incorporation assay showed similar results. 
Changes in the phospholipid bilayer of the cell membrane 
were also observed early in apoptosis. The phosphatidylserine 
component of the phospholipid bilayer was externalized 
and could be detected by fluorescence labeling. Annexin 
V has a high affinity for the phosphatidylserine-containing 
phospholipid bilayer. Staining with FITC-conjugated 
Annexin V and propidium iodide can identify subpopulations 
of cells with membrane changes and any associated loss of 
membrane integrity. In this study, further apoptotic induction 
studies by Annexin-propidium iodide staining confirmed 
that the AuNP-conjugated molecules could reduce apoptosis International Journal of Nanomedicine 2011:6
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Figure 1 Ultraviolet-visible spectra of Au-2-BNQ, Au-2,3-DBNQ, and Au-PAM-PB nanoconjugates. Using different concentrations of conjugates (10 µg/mL of AuNP solution), 
an increase in absorbance of (A) Au-2-BNQ at 350 nm and (B) Au-2,3-DBNQ at 360 nm is observed with increasing concentrations of 2-BNQ (10, 20, 30, and 50 µg/mL) and 
2,3-DBNQ (10, 15, 20, 25 and 30 µg/mL), respectively, up to 20 µg/mL is seen, and then a decrease. Absorbance increases up to 20 µg/mL and then the absorbance decreases 
with increasing concentrations of both 2-BNQ and 2,3-DBNQ. (C) Similarly, imilarly, for Au-PAM-PB (5, 10, 15, 20, 30, 40, and 50 µg/mL), the absorbance at 420 nm increases 
to a maximum at 30 µg/mL and then decreases with an increase in concentration of plumbagin. All experiments were performed three times with similar results.
Abbreviations: Au, gold; 2-BNQ, 2-bromo-1,4-naphthoquinone; 2,3-DBNQ, 2,3-dibromo-1,4-naphthoquinone; PB, plumbagin; PAM, polyethylene glycol-amine.
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more than the pristine compounds alone (Figure 5). Similar 
results showing the inhibitory effect of anisamide-targeted 
liposomal doxorubicin on the growth of DU-145 tumors 
were reported by Banerjee et al, who showed that despite 
the improved targeting, doxorubicin formulated in liposomes 
containing distearoylglycerol phosphatidylethanolamine 
polyethylene glycol(3400)- -[2-(4-methoxybenzamido)] 
ethylamine were less potent than the free drug. This might 
be due to the fact that the tumor cells were exposed to the 
free drug for an extended period of time.27 In vivo, this 
condition might not occur as the free drug is rapidly cleared 
after administration.International Journal of Nanomedicine 2011:6
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Figure 2 Ultraviolet-visible spectral readings of AuNP and nanoconjugates indicating the change in peak of wavelength (shift in λmax) of gold nanoparticles with increasing 
concentrations of (A) 2-BNQ, (B) 2,3-DBNQ, and (C) Au-PAM-PB. A predicted schematic diagram of Au-PAM-PB complex is shown in (D). Au-PAM may conjugate with 
plumbagin by amide bonding. 
Abbreviations: Au, gold; 2-BNQ, 2-bromo-1,4-naphthoquinone; 2,3-DBNQ, 2,3-dibromo-1,4-naphthoquinone; PB, plumbagin; PAM, polyethylene glycol-diamine.
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Figure 3 Release profiles for plumbagin from Au-PAM-PB nanoconjugates. There was a constant release of plumbagin from Au-PAM-PB for up to six hours in phosphate-
buffered solution at ph 7.4. 
Abbreviations: Au, gold; PB, plumbagin; PAM, polyethylene glycol-amine.
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p53 and apoptosis
Apoptosis can be p53-dependent or p53-independent. 
Plumbagin is reported specifically to inhibit p300-mediated 
acetylation of p53, making it susceptible to ubiquitination. 
The chemical entity in plumbagin responsible for inhibi-
tion of acetyltransferase activity is the hydroxyl group.28 
Here we observed that treatment with plumbagin but not with 
  Au-PAM-PB could inhibit p53 protein expression (Figure 6). 
2-BNQ and 2,3-DBNQ and their gold conjugates did not 
inhibit p53. This might be due to the lack of a hydroxyl group 
in these quinones. This indirectly shows that AuNP can change 
the electrophilicity of the hydroxyl group on plumbagin.International Journal of Nanomedicine 2011:6
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Figure 4 (A) MTS cell proliferation assay with naphthoquinones in MDA-MB-231 cells. concentrations of all free compounds and compounds with AuNP conjugates were 
constant (100 nM) as indicated. The concentration was calculated from the standard curve drawn using the absorbance obtained at 420, 350, and 360 nm for plumbagin, 2-BNQ, 
and 2,3-DBNQ, respectively. MTS reading was taken after 48 hours of incubation with the compounds and AuNP conjugates. (B) Thymidine incorporation assay also showed 
fewer S phase cells in those treated with the pristine compound compared than the AuNP conjugates. The experiment was repeated at least three times, with similar results. 
Abbreviations: Au, gold; 2-BNQ, 2-bromo-1,4-naphthoquinone; 2,3-DBNQ, 2,3-dibromo-1,4-naphthoquinone; PB, plumbagin; NP, nanoparticles.
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Figure 5 cells were counted after Annexin-propidium iodide staining. cells with bound Annexin V show green staining in the plasma membrane. cells that have lost 
membrane integrity show red staining (propidium iodide) throughout the cytoplasm. Flow cytometric analysis showed live (no stain), early apoptotic cells (only annexin 
staining), late apoptotic cells (both annexin and propidium iodide staining), and dead (propidium iodide staining) cells. Most of the plumbagin-treated cells were in the late 
apoptotic stage, whereas the AuNP conjugates had fewer numbers of late apoptotic cells. More live cells are observed in AuNP conjugates than in samples treated with the 
pristine compound. A t-test showed a statistically significant difference between the percentage of late apoptotic cells induced by plumbagin versus Au-PAM-PB and 2,3-
DBNQ versus Au-2,3-DBNQ. The experiment was repeated at least three times with similar results. 
Abbreviations:  Au,  gold;  2-BNQ,  2-bromo-1,4-naphthoquinone;  2,3-DBNQ,  2,3-dibromo-1,4-naphthoquinone;  PB,  plumbagin;  PAM,  polyethylene  glycol-amine;  NP, 
nanoparticles.
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Figure 6 Western blot analysis of p53 protein expression showed that only plumbagin-treated cells had reduced expression of p53 at 100 nM concentration.
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Figure  7  cellular  uptake  of  Au-PAM-PB.  Transmission  electron  microscopic 
analysis  of  MDA-MB-231  cells  treated  with  Au-PAM-PB  100  nM  for  24  hours 
showed internalization of Au-PAM-PB by lysosomes in the cells. Magnifications of 
the figures shown as (A) 6000×, (B) 20,000×, and (C) 80,000×. The experiment was 
repeated at least three times with similar results. 
Abbreviations: Au, gold; PB, plumbagin; PAM, polyethylene glycol-amine.
Au-PAM-PB aggregates in lysosomes
MDA-MB-231 cells were treated with 1 µM Au-PAM-PB 
for 24 hours, and their localization inside the cells was 
checked by transmission electron microscopy, revealing 
uptake of synthesized AuNP in vacuoles and lysosomes 
in the cytoplasmic compartment, as shown in Figure 7. 
AuNP are reported to be internalized in the cell and to 
accumulate inside lysosomes.29 However, in this study, it 
was not analyzed whether the AuNP found in the lysosomes 
contained bound plumbagin or not.
AuNP quenches production of reactive 
oxygen species by naphthoquinones
The ability of AuNP-conjugated plumbagin to generate reac-
tive oxygen species was analyzed because plumbagin is a 
well known generator of reactive oxygen species.10,11 There is 
extensive electron delocalization between the C1 to C4 carbon 
atoms, which is responsible for the reversible redox cycling 
observed for plumbagin (by electrochemical measurement) 
whereby it generates successive semiquinone and catecholic 
forms. The intermediate semiquinone formed is highly reac-
tive and interacts with molecular dioxygen species present 
in biological systems to oxidize itself back to the original 
quinone form, while the molecular oxygen gets reduced 
to superoxide species. This is what is commonly known as 
“redox cycling” of quinones, and is responsible for most of 
their biological activity. As we observed quenching of the 
redox cycling behavior of plumbagin upon making an AuNP 
conjugate, such conjugation does not allow or favor addition 
of one electron in the lowest unoccupied molecular orbits. 
This could be due to substitution of electrons, withdrawing a 
chloro/bromo substituent at the C3/C2 position or perturbation 
by the molecular orbits of gold in the quinone reduction. It has 
been reported that AuNP can cause an approximately 1.5-fold 
increase in reactive oxygen species levels in human hepa-
toma cells.30 Another report by Ito et al31 showed that AuNP 
increase the yield of reactive oxygen species and that the 
antioxidant enzymes, catalase and superoxide dismutase, are 
both effective in reducing the total amount of reactive oxygen 
species.31 This analysis was done using electron paramagnetic 
resonance spectroscopy in cell-free media. Other reports 
also show that AuNP can cause elevation of reactive oxygen 
species levels without cytotoxicity.32,33 On the other hand, 
quinones can undergo intracellular electron reduction to the 
hydroquinone or to the semiquinone.34,35 The semiquinone or 
hydroquinone may regenerate quinone through redox cycling 
by reacting with molecular oxygen to produce superoxide International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 8 reactive oxygen species generation study with DcFh-DAh2 staining. h2O2 production was detected using nonfluorescent DCFH-DAH2 dye, which when oxidized 
is converted into fluorescent 2′,7′-dichlorofluorescein (excitation 488 nm, emission 540 nm). The AuNP conjugates and AuNP alone could not induce reactive oxygen species 
production, while the positive control (10 µM h2O2) and the pristine compounds generated reactive oxygen species. The experiment was repeated at least three times with 
similar results. 
Abbreviations: Au, gold; NP, nanoparticles.
radicals. This may culminate in damage to macromolecules 
and cytotoxicity.36 The production of oxygen radicals and the 
cytotoxic damage vary for different quinones and in different 
environments.37,38 Thus, both AuNP and naphthoquinones 
generate reactive oxygen species. However, AuNP-conjugated 
naphthoquinones might exhibit a relative antioxidant poten-
tial compared with the pristine compounds. It is known that 
antioxidant capacity is a relative phenomenon. A pro-oxidant 
may become antioxidant when it encounters a stronger pro-
oxidant. Similarly, an antioxidant may become pro-oxidant 
depending on the redox potential. Therefore, interpretation 
of the antioxidant/pro-oxidant status of chemical entities 
should be done only after considering these issues. We had 
shown earlier that pretreatment of cells with N-acetylcysteine, 
an antioxidant, protected cells from undergoing apoptosis, 
confirming the role of reactive oxygen species in plumbagin-
mediated apoptosis.39 Here we have found that the capacity 
of plumbagin to generate reactive oxygen species, which is 
the major mechanism of action, can be quenched by AuNP 
conjugation through PEG, which shows that cytotoxicity can 
be reduced by gold nanoconjugation (Figure 8). However, 
further studies need to be done to confirm this in vivo.
Conclusion
We have synthesized AuNP and their conjugates with plumbagin, 
2-BNQ, and 2,3-DBNQ molecules and characterized them by 
several physicochemical techniques. We have also studied 
the anticancer activity of the free and gold nanoconjugated 
compounds. We have shown that the cytotoxicity of the free 
compounds can be reduced by conjugation with AuNP. A 
plausible mechanism might be less production of reactive 
oxygen species when these compounds are conjugated with 
AuNP. The outcome of targeted chemotherapy depends 
mainly on two factors, ie, the ability of the carrier molecule 
to recognize malignant cells selectively and the nature of the 
chemical linkage used for coupling the cytotoxic agent to the 
carrier. Chemical bonding between plumbagin and AuNP-
PAM might affect the hydroxyl group of plumbagin, ie, the 
electrophilic moiety, making it a less toxic molecule, resulting 
in an ability to quench reactive oxygen species. Further stud-
ies of these AuNP-naphthoquinone conjugates with targeting 
antibodies or liposomes might enable these compounds to be 
administered with targeted cytotoxicity in a safe manner.
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